alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Justice Drug Enforcement Administration [Docket No. DEA-392]
 ACTION: Notice of application.
 DATES: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before August 31, 2018. Such persons may also file a written request for a hearing on the application on or before August 31, 2018.
 ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All request for hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152.


SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been delegated to the Assistant Administrator of the DEA Diversion Control Division (“Assistant Administrator”) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.34(a), this is notice that on July 3, 2018, Galephar Pharmaceutical Research Inc., #100 Carr 198 Industrial Park, Juncos, Puerto Rico 00777 applied to be registered as an importer of the following basic class of controlled substance: Controlled substance
Drug 
                             code
ScheduleHydromorphone
9150
II
 The company plans to import the listed controlled substance in finished dosage form for clinical trials, research and analytical purposes. Dated: July 23, 2018. John J. Martin, Assistant Administrator.


[FR Doc. 2018-16466 Filed 7-31-18; 8:45 am] BILLING CODE 4410-09-P
Exhibit



Exhibit 10.7








August 25, 2016


WCW (Willie) Chiang




Re:    Amendment of Phantom Unit Grant Letter dated August 24, 2015


Dear Willie:


The Compensation Committee and Board of Directors of Plains All American GP LLC has approved certain modifications to the vesting terms of your long term incentive plan grant letter dated August 24, 2015 (the “August 2015 Grant Letter”).  Accordingly, effective as of the date of this letter, the August 2015 Grant Letter is hereby amended to replace paragraph 1 thereof in its entirety with the following:


		
	1.
	Subject to the further provisions of this Agreement, your Phantom Units shall vest (become payable in the form of one Common Unit of PAA for each Phantom Unit) as follows: (i) forty percent (40%) shall vest upon the later to occur of the August 2018 Distribution Date and the first date following the date hereof on which the Partnership pays a quarterly distribution of at least $0.575 per unit ($2.30 on an annualized basis); (ii) thirty percent (30%) shall vest upon the later to occur of the August 2019 Distribution Date and the first date following the date hereof on which the Partnership pays a quarterly distribution of at least $0.60 per unit ($2.40 on an annualized basis) and (iii) thirty percent (30%) shall vest upon the later to occur of the August 2020 Distribution Date and the first date following the date hereof on which the Partnership pays a quarterly distribution of at least $0.625 per unit ($2.50 on an annualized basis). Any remaining Phantom Units that are not vested by the August 2021 Distribution Date, and any tandem DERs associated with such Phantom Units, shall expire on such date.  




Except as amended hereunder, the August 2015 Grant Letter shall remain in full force and effect according to its terms. 


PLAINS ALL AMERICAN PIPELINE, L.P.


By:  PAA GP LLC
By:  PLAINS AAP, L.P.
By:  PLAINS ALL AMERICAN GP LLC




		
	By:
	/s/ Richard K. McGee                                     


		
	Name:
	Richard K. McGee


		
	Title:
	Executive Vice President & General Counsel






333 Clay Street, Suite 1600   g  Houston, Texas  77002  g  713/646-4100 or 800-564-3036
# C_2013187EN.01000501.xml

| 29.6.2013 | EN | Official Journal of the European Union | C 187/5 |
| --- | --- | --- | --- |

29.6.2013

EN

Official Journal of the European Union

C 187/5

---

Non-opposition to a notified concentration

(Case COMP/M.6942 — PAI Partners/R&R)

(Text with EEA relevance)

2013/C 187/02

On 24 June 2013, the Commission decided not to oppose the above notified concentration and to declare it compatible with the common market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004. The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/en/index.htm) under document number 32013M6942. EUR-Lex is the on-line access to the European law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/en/index.htm) under document number 32013M6942. EUR-Lex is the on-line access to the European law.

---
DISMISS; and Opinion Filed January 14, 2014.

In The

Court of Appeals

Fifth District of Texas at Dallas

No. 05-13-01247-CR

No. 05-13-01248-CR

ANNA EDWYNA MITCHELL, Appellant

V.

THE STATE OF TEXAS, Appellee

On Appeal from the 196th Judicial District Court

Hunt County, Texas

Trial Court Cause Nos. 28770, 28771

MEMORANDUM OPINION

Before Justices O’Neill, Myers, and Brown

Appellant has filed a motion to dismiss the appeals. Appellant’s counsel has approved 

the motion. The Court GRANTS the January 10, 2014 amended motion and ORDERS that the 

appeals be DISMISSED and this decision be certified below for observance. See TEX. R. APP.

P. 42.2(a).

PER CURIAM

Do Not Publish

TEX. R. APP. P. 47

131248F.U05
Exhibit



Exhibit 10.2





FIRST AMENDMENT
TO
STARZ SEVERANCE AGREEMENT
WITH
Carmi Zlotnik (the “Executive”)
This First Amendment to Starz Severance Agreement (the “Amendment”) is entered into as of the 6th day of September, 2016 (the “Amendment Date”) by and between Starz Entertainment, LLC (the “Employer”) and the Executive named above.
The Employer and the Executive entered into a Starz Severance Agreement dated as of April 1, 2014 (the “Agreement”), pertaining to severance benefits if the Executive’s employment with the Employer is terminated in a Qualifying Termination.
1.Amendment.  Section 1(d)(i) of the Agreement is hereby deleted in its entirety and replaced with the following:
“i.    A lump sum payment equal to 70% of the Executive’s Severance Pay Amount, which will be paid within 60 days following such termination date; and”
2.No Other Changes.  Subject solely to the modifications expressly set forth in this Amendment, the Agreement will remain in full force and effect.
3.Definitions.  Capitalized terms used and not otherwise defined in this Amendment will have the meanings ascribed to them in the Agreement.
IN WITNESS WHEREOF, the Employer and the Executive have signed this Amendment to be effective as of the Amendment Date.
Employer:


Starz Entertainment, LLC




By:    /s/ Christopher Albrecht
Name:  Christopher Albrecht
Title:  President and CEO




Executive:




/s/ Carmi D. Zlotnik                            
Carmi D. Zlotnik












Starz Confidential
Exhibit 10.36


 


SECOND AMENDMENT OF SALE-PURCHASE AGREEMENT


 


THIS SECOND
AMENDMENT OF SALE-PURCHASE AGREEMENT (this “Amendment”) is made effective as of August 24, 2016,
by and between RPG GLENRIDGE LLC, a Delaware limited liability company (“Seller”), and CARROLL
ACQUISITIONS, LLC, a Georgia limited liability company (“Purchaser”), on the following terms and
conditions:


 


RECITALS:


 


A.           Seller
and Purchaser entered into that Sale-Purchase Agreement dated August 12, 2016, as amended by that First Amendment of Sale-Purchase
Agreement dated August 19, 2016 (as amended, the “Agreement”; all capitalized terms in this Amendment,
unless otherwise defined herein, having the same meanings assigned to such terms in the Agreement) for the sale by Seller to Purchaser
of property located in Fulton County, Georgia, as more particularly described therein; and


 


B.           Seller
and Purchaser desire to amend the Agreement as herein provided.


 


AMENDMENT:


 


NOW, THEREFORE,
for the premises considered, and for valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Seller
and Purchaser amend the Agreement as follows:


 


1.          Due
Diligence Date. The term “Due Diligence Period” as set forth in Section 35 of the Agreement and
referred to elsewhere in the Agreement is hereby amended and shall hereafter be defined as the period beginning on the Effective
Date and ending on August 25, 2016, at 5:00 P.M. (New York time).


 


2.          Full
Force and Effect. As amended in this Amendment, the Agreement continues in full force and effect.


 


3.          Counterparts.
This Amendment may be executed in several counterparts, each of which shall be deemed an original, and all of such counterparts
together shall constitute one and the same instrument.


 


[THE REMAINDER OF THIS PAGE INTENTIONALLY LEFT
BLANK.]


 




    	 	1	 



     


    

 


 


IN WITNESS WHEREOF,
this Amendment has been duly executed by the parties hereto as of the Effective Date.


 


	 	SELLER:
	 	 
	 	RPG GLENRIDGE LLC,
	 	a Delaware limited liability company
	 	 	 
	 	By: 	/s/ Michael Betancourt
	 	 Name: Michael Betancourt 
	 	 Title:   Authorized Signatory


 


	 	PURCHASER:
	 	 
	 	CARROLL ACQUISITIONS, LLC,
	 	a Georgia limited liability company
	 	 	 
	 	By: 	/s/ Josh Champion
	 	 Name: Josh Champion
	 	 Title:   President


 




    	 	2
```

[Federal Register Volume 83, Number 156 (Monday, August 13, 2018)]
[Notices]
[Pages 40073-40074]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-17341]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND

HUMAN SERVICES National Institutes of Health

National Heart, Lung, and Blood Institute; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the National Heart, 
Lung, and Blood Advisory Council.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations should notify the Contact Person listed 
below in advance of the meeting.

    Name of Committee: National Heart, Lung, and Blood Advisory 
Council.
    Date: September 5, 2018.
    Open: 8:00 a.m. to 1:30 p.m.
    Agenda: To discuss program policies and issues.
    Place: National Institutes of Health, Building 35A, Porter 
Building, Room 640, 35A Convent Drive, Bethesda, MD 20892.
    Open: 2:30 p.m. to 3:00 p.m.
    Agenda: To discuss program policies and issues.
    Place: National Institutes of Health, Building 35A, Porter 
Building, Room 640, 35A Convent Drive, Bethesda, MD 20892.
    Contact Person: Laura K. Moen, Ph.D., Director, Division of 
Extramural Research Activities, National Heart, Lung, and Blood 
Institute, National Institutes of Health, 6701 Rockledge Drive, Room 
7100, Bethesda, MD 20892, 301-435-0260, [email protected].
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    In the interest of security, NIH has instituted stringent 
procedures for entrance onto the NIH campus. All visitor vehicles,

[[Page 40074]]

including taxicabs, hotel, and airport shuttles will be inspected 
before being allowed on campus. Visitors will be asked to show one 
form of identification (for example, a government-issued photo ID, 
driver's license, or passport) and to state the purpose of their 
visit.
    Information is also available on the Institute's/Center's home 
page: www.nhlbi.nih.gov/meetings/nhlbac/index.htm, where an agenda 
and any additional information for the meeting will be posted when 
available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS)

    Dated: August 8, 2018.
David D. Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-17341 Filed 8-10-18; 8:45 am]
 BILLING CODE 4140-01-P
```
# C_2013222EN.01000402.xml

| 2.8.2013 | EN | Official Journal of the European Union | C 222/4 |
| --- | --- | --- | --- |

2.8.2013

EN

Official Journal of the European Union

C 222/4

---

Non-opposition to a notified concentration

(Case COMP/M.6912 — Michael S. Dell/Dell)

(Text with EEA relevance)

2013/C 222/03

On 20 June 2013, the Commission decided not to oppose the above notified concentration and to declare it compatible with the common market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004. The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/en/index.htm) under document number 32013M6912. EUR-Lex is the on-line access to the European law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/en/index.htm) under document number 32013M6912. EUR-Lex is the on-line access to the European law.

---
I

103D CONGRESS

1ST SESSION H. R. 2934

To amend the Fair Labor Standards Act of 1938 to provide that the Commonwealth of Northern Mariana Islands shall be covered under the

minimum wage provisions of that Act on the same basis as American

Samoa.

IN THE HOUSE OF REPRESENTATIVES

AUGUST 6, 1993

Mr. FALEOMAVAEGA introduced the following bill; which was referred to the

Committee on Education and Labor

A BILL

To amend the Fair Labor Standards Act of 1938 to provide

that the Commonwealth of Northern Mariana Islands

shall be covered under the minimum wage provisions

of that Act on the same basis as American Samoa.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. INDUSTRY COMMITTEES.

4 (a) SECTION 5.—Section 5 of the Fair Labor Stand5 ards Act of 1938 (29 U.S.C. 205) is amended—

6 (1) in the title, by inserting AND COMMON7 WEALTH OF NORTHERN MARIANA ISLANDS after

8 AMERICAN SAMOA, and
2

•HR 2934 IH

1 (2) in the first sentence, by inserting ‘‘and in

2 the Commonwealth of Northern Mariana Islands’’

3 after ‘‘American Samoa’’, and

4 (3) in the second sentence, by inserting ‘‘or the

5 Commonwealth of Northern Mariana Islands, as the

6 case may be,’’ after ‘‘American Samoa’’ each place

7 it appears.

8 (b) SECTION 6.—Section 6(a)(3) of the Fair Labor

9 Standards Act of 1938 (29 U.S.C. 206(a)(3)) is amended

10 by inserting ‘‘or in the Commonwealth of Northern Mari11 ana Islands’’ after ‘‘American Samoa’’.

12 (c) SECTION 8.—Section 8 of the Fair Labor Stand13 ards Act of 1938 (29 U.S.C. 208) is amended—

14 (1) in the title, by inserting AND THE COMMON15 WEALTH OF NORTHERN MARIANA ISLANDS after

16 AMERICAN SAMOA, and

17 (2) in subsection (a), by inserting ‘‘and in the

18 Commonwealth of Northern Mariana Islands’’ after

19 ‘‘American Samoa’’ each place it occurs, and

20 (3) in subsection (b), by inserting ‘‘or in the

21 Commonwealth of Northern Mariana Islands’’ after

22 ‘‘in American Samoa’’ and by inserting ‘‘or the

23 Commonwealth of Northern Mariana Islands’’ after

24 ‘‘of American Samoa’’.

Æ
#### CHARLES SALES CORP., a Florida corporation, Appellant, v. FLORIDA INTER-ISLAND SHIPPING CORPORATION, a Florida corporation, trading and doing business as Florida Lines, Appellee.

No. 71-1315.

District Court of Appeal of Florida, Third District.

May 16, 1972.

Rehearing Denied June 12, 1972.

PER CURIAM.

Affirmed.
```

[Congressional Bills 113th Congress]
[From the U.S. Government Publishing Office]
[S. 1967 Introduced in Senate (IS)]

113th CONGRESS
  2d Session
                                S. 1967

 To provide for the management of certain inventoried roadless areas, 
                        and for other purposes.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                            January 28, 2014

 Mr. Barrasso introduced the following bill; which was read twice and 
       referred to the Committee on Energy and Natural Resources

_______________________________________________________________________

                                 A BILL

 
 To provide for the management of certain inventoried roadless areas, 
                        and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Inventoried Roadless Area Management 
Act''.

SEC. 2. MANAGEMENT OF INVENTORIED ROADLESS AREAS.

    (a) Finding.--Congress finds that, for purposes of the second 
roadless area review and evaluation program (RARE II) and the land and 
resource management plan revision process under section 6 of the Forest 
and Rangeland Renewable Resources Planning Act of 1974 (16 U.S.C. 
1604), the National Forest System land described in subsection (c) has 
been adequately studied for wilderness designation and should not be 
recommended as potential additions to the National Wilderness 
Preservation System.
    (b) Release.--The National Forest System land described in 
subsection (c)--
            (1) is no longer subject to the land use restrictions of 
        the Roadless Area Conservation Rule established under part 294 
        of title 36, Code of Federal Regulations (or successor 
        regulations); and
            (2) shall not be managed to preserve roadless or wilderness 
        characteristics.
    (c) Description of Land.--The National Forest System land referred 
to in subsections (a) and (b) is each of the inventoried roadless areas 
within the National Forest System in the State of Wyoming, as set forth 
in the maps contained in the Forest Service Roadless Area Conservation, 
Final Environmental Impact Statement, Volume 2, dated November 2000.
                                 <all>
```
,-.m o r e t h M t h a

lrount aoodod

# to

pay 

# thr

m-8 8bOVS 

### l p u l f l.ed ,

a a m. s h a ll . b a de -6 OXO ~~ f~o and ohdl k dispo8.d of la

# the

-or hdual’ t.r poprldad.
*In aouatiro **tuuitpfive** tlumwd (25,000)

or 1~08 Fllstrict andcouRtyoo'ifiouoMud ka r d ll l a1.l retain OM-thM Of OU?hUMO8 fU8 Until SUUh@M.

wick tlm *WJtU&S

### l

pealfbd 

### in o mu a o t o TJW O Q Tho uBud

m l- P r u i u o t

ofriaus 

### o h & l

robin onethird utll auuh one-t&-d, t&o mulat 7.r

d.fbd in ktioi8 ) ~%iOi% to Fourtoon 'Qndmd ml&r8 (#uoo).:..*,-

~ploionHe.o-2582 ofthsada rtm~#lt doaltuiaba oLtuat* r e l a tive t othe l

aluLea o f

t r e o ff t a u o

o f TravLai-ioawr4bl.m Than8 A. &bent,

**Ar ’**  **kid~** 39Ua, **%JtiOn** X3, **V.A.C.3.** aadtht 

# thmmnxlh oa ll o w a 4

l och off&oar

YJI the mxtmm afflorr

by. laws eal&nc Austut 26, 1935, W melon hueuithrcopyof
Oplalen**Ho. O-2560**  of'thla de~artmmnt

holds **that** tbn CdLh4mmrd court of **Llmsstonm** Cot7nt.y Tu n8 ,

s h o u l d fi x t & i l alarlae

o f the o ff i a l a l*

o fa & i **couaty rmmd.**  **la&rGlclr 39120,**  Sm. 13, V.*.C.3., for the yeu low4 thatha mlalmm ml4x-y OfO4Ch mnch offloar

aamwc br lerr thaatho Mt3 au' onrnoda8 **omtloa b**  h&o **la htr**  oftlaW **cnpacity** for the fbl)ul9$5ala8t~ttho-~ofsllch rhoYemacloa4d 0fflo.r eouu k the audwm uottat



# C o u nt y

Oa Aryut24 1935, the 

# % x 48; l **ccordfal: to**  **the** t **r** pulntlm of Liberty **en hat**  **proceding hmsi**  **cenmu of**  **1930 CIU**  19 **bbd khabiunta**  **and** ntthmttiam **co-wit** ~u@st **24** 1935 

### thearlauo amoaat rllo&l the c&nty a& dbtrld offlcrrs of Liberty

Couaty',

Texzw,**aadbr** Arttcles 3883 uut $391, **Verxwa~cr**

**hniwtated &mm**  **Civil Statutes,**  **uas tbs**  **IU~** of **&3,oMwxL**

**Ten nrr)**  rmqeatfullpadvlamd **tht it**  **la tb**  **0pirJo.n** of **this &pwtm@ls**  **the naldma**  aalwlen **of tb**  

### uouat offlciirlr

of Llbarty

Zouuty,T-6, nmed fn melo 

### L 39Ue, Sat.lcm13 

### ~.A.C.S.,**for the**  **y-r** 19J4 

### apnacrt **exceed**

the aUa of 43 000.00 +Sla OTPI pU' aetrt char*& for eachmllllon**doh.ar** veluntlcra or fractlond.
P fi t hm r s o f ln l x a me a o f ftfc mm nm llll o n cloU4rs. **m aanple,**  If tile

88II(LSmu3

val~litlark

of L%bertY. glrornS~

.

,

. . ..